Asymmetric dimethylarginine may mediate increased heat pain threshold in experimental chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 27, Issue 3, 2012, Pages 899-902

  Kielstein, Jan T ^a   Suntharalingam, Mayuren ^a   Perthel, Ronny ^a   Rong, Song ^a   Martens Lobenhoffer, Jens ^b   Jäger, Kristin ^c   Bode Böger, Stefanie M ^b   Nave, Heike ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

ADMA; Brain function; Nociception; SDMA; Uraemia

Indexed keywords

6 N,N' DIMETHYLARGININE; CREATININE; N(G),N(G) DIMETHYLARGININE; SODIUM CHLORIDE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BRAIN FUNCTION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FLOW RATE; HEAT SENSITIVITY; HOT PLATE TEST; KIDNEY FUNCTION TEST; LATENT PERIOD; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NOCICEPTIVE PAIN; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; UREA BLOOD LEVEL; WEIGHT REDUCTION;

ANIMALS; ARGININE; ENZYME INHIBITORS; HOT TEMPERATURE; KIDNEY FAILURE, CHRONIC; MALE; NEPHRECTOMY; NITRIC OXIDE SYNTHASE; PAIN; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84861155651     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr629     Document Type: Article

References (23)

1. Cohen SD, Patel SS, Khetpal P et al. Pain, sleep disturbance, and quality of life in patients with chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 919-925
2. Pham PC, Dewar K, Hashmi S et al. Pain prevalence in patients with chronic kidney disease. Clin Nephrol 2010; 73: 294-299
3. Lindblom U, Tegner R. Thermal sensitivity in uremic neuropathy. Acta Neurol Scand 1985; 71: 290-294
4. Laaksonen S, Metsarinne K, Voipio-Pulkki LM et al. Neurophysiologic parameters and symptoms in chronic renal failure. Muscle Nerve 2002; 25: 884-890
5. Chen Y, Boettger MK, Reif A et al. Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice. Mol Pain 2010; 6: 13
6. Ozek M, Uresin Y, Gungor M. Comparison of the effects of specific and nonspecific inhibition of nitric oxide synthase on morphine analgesia, tolerance and dependence in mice. Life Sci 2003; 72: 1943-1951
7. Kielstein A, Tsikas D, Galloway GP et al. Asymmetric dimethylarginine (ADMA)-A modulator of nociception in opiate tolerance and addiction? Nitric Oxide 2007; 17: 55-59
8. Cardounel AJ, Zweier JL. Endogenous methylarginines regulate neuronal nitric-oxide synthase and prevent excitotoxic injury. J Biol Chem 2002; 277: 33995-34002
9. Kielstein JT, Zoccali C. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis 2005; 46: 186-202
10. Bahlmann FH, Song R, Boehm SM et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 2004; 110: 1006-1012
11. Buchenauer T, Behrendt P, Bode FJ et al. Diet-induced obesity alters behavior as well as serum levels of corticosterone in F344 rats. Physiol Behav 2009; 98: 563-569
12. Martens-Lobenhoffer J, Bode-Boger SM. Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography-electrospray tandem mass spectrometry. Clin Chem 2006; 52: 488-493
13. Cupisti A, Saba A, D'Alessandro C et al. Dimethylarginine levels and nutritional status in hemodialysis patients. J Nephrol 2009; 22: 623-629
14. Kielstein JT, Salpeter SR, Bode-Boeger SM et al. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function-a meta-analysis. Nephrol Dial Transplant 2006; 21: 2446-2451
15. Kielstein JT, Veldink H, Martens-Lobenhoffer J et al. SDMA is an early marker of change in GFR after living-related kidney donation. Nephrol Dial Transplant 2011; 26: 324-328
16. Wong BJ, Fieger SM. Transient receptor potential vanilloid type-1 (TRPV-1) channels contribute to cutaneous thermal hyperaemia in humans. J Physiol 2010; 588: 4317-4326
17. Kielstein JT, Fliser D, Veldink H. Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance? Semin Dial 2009; 22: 346-350
18. Moore PK, Oluyomi AO, Babbedge RC et al. L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 1991; 102: 198-202
19. Kielstein JT, Impraim B, Simmel S et al. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 2004; 109: 172-177
20. Schmidtko A, Tegeder I, Geisslinger G. No no, no pain? The role of nitric oxide and cGMP in spinal pain processing. Trends Neurosci 2009; 32: 339-346
21. Dixon SJ, Persinger MA. Suppression of analgesia in rats induced by morphine or L-NAME but not both drugs by microTesla, frequencymodulated magnetic fields. Int J Neurosci 2001; 108: 87-97
22. Zoccali C, Maas R, Cutrupi S et al. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant 2007; 22: 801-806
23. Vanholder R, Abou-Deif O, Argiles A et al. The role of EUTox in uremic toxin research. Semin Dial 2009; 22: 323-328